Eleison Pharmaceuticals Inc. (ELSN)

Eleison Pharmaceuticals was planning to go public, but the IPO was withdrawn on Jun 29, 2023.

Stock Price: Pending

IPO price not available yet

Eleison Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2020	2019
Revenue	1	1.07
Revenue Growth (YoY)	-6.25%	-
Gross Profit	1	1.07
Selling, General & Admin	0.87	0.54
Research & Development	0.67	0.97
Operating Expenses	1.54	1.51
Operating Income	-0.54	-0.44
Interest Expense / Income	1.37	1.29
Other Expense / Income	3.9	-0.01
Pretax Income	-6.4	-1.72
Net Income	-5.8	-1.72
Preferred Dividends	-0.6	-
Net Income Common	-6.4	-1.72
Free Cash Flow	-6.52	-1
Gross Margin	100.00%	100.00%
Operating Margin	-54.02%	-41.26%
Profit Margin	-640.30%	-161.65%
Free Cash Flow Margin	-651.68%	-93.74%
EBITDA	-3.8	-0.36
EBITDA Margin	-379.83%	-33.64%
Depreciation & Amortization	0.04	0.08
EBIT	-3.84	-0.43
EBIT Margin	-383.86%	-40.78%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).